Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular involvement in systemic sclerosis (SSc).

M B Kahaleh1

  • 1Division of Rheumatology, Department of Medicine, Medical College of Ohio, 3 Toledo, Ohio 43614-5809, USA.

Clinical and Experimental Rheumatology
|September 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of substance P mRNA expression in human dermal microvascular endothelial cells.

Clinical and experimental rheumatology·2004
Same author

Beauty and the beast. The nitric oxide paradox in systemic sclerosis.

Rheumatology (Oxford, England)·2002
Same author

Reproducible gene expression measurement among multiple laboratories obtained in a blinded study using standardized RT (StaRT)-PCR.

Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology·2002
Same author

Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome.

Chest·2001
Same author

Autoimmunity and vascular involvement in systemic sclerosis (SSc).

Autoimmunity·2000
Same author

Gammadelta receptor bearing T cells in scleroderma: enhanced interaction with vascular endothelial cells in vitro.

Clinical immunology (Orlando, Fla.)·1999
Same journal

The expanded cardiovascular risk prediction score as a cardiovascular mortality predictor in rheumatoid arthritis.

Clinical and experimental rheumatology·2026
Same journal

Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison.

Clinical and experimental rheumatology·2026
Same journal

Clinical features and gastrointestinal bleeding risk factors in IgA vasculitis patients: a retrospective study in a large volume centre.

Clinical and experimental rheumatology·2026
Same journal

Reply to the comment on: The microbiota in axial spondyloarthritis: what have we learned from Mendelian randomisation studies?

Clinical and experimental rheumatology·2026
Same journal

Comprehensive evaluation of bone structural and microarchitectural changes in rheumatoid arthritis treated with baricitinib using HR-pQCT, imaging, and biomarker analyses.

Clinical and experimental rheumatology·2026
Same journal

Tracking interstitial lung disease in systemic sclerosis: integrating lung magnetic resonance imaging into a clinically oriented multimodal follow-up strategy.

Clinical and experimental rheumatology·2026
See all related articles

Dr. LeRoy

Area of Science:

  • Vascular Biology
  • Scleroderma Pathogenesis
  • Endothelial Cell Research

Background:

  • The vascular hypothesis in scleroderma pathogenesis was introduced by Dr. LeRoy.
  • Vascular cells, including endothelial cells, have been a key focus in scleroderma research.
  • Understanding scleroderma's etiology, pathogenesis, and treatment has been advanced by studying vascular aspects.

Purpose of the Study:

  • To review Dr. LeRoy's contributions to scleroderma research.
  • To summarize progress in understanding scleroderma vascular disease since the vascular hypothesis.
  • To consolidate current knowledge on vascular disease in scleroderma.

Main Methods:

  • Literature review of studies on scleroderma pathogenesis.
  • Analysis of research progress following the introduction of the vascular hypothesis.

Related Experiment Videos

  • Synthesis of findings related to vascular disease in scleroderma.

    • Main Results:

    • The vascular endothelium is central to scleroderma pathogenesis.
    • Significant advancements have been made in understanding scleroderma's vascular components.
    • Current knowledge highlights the critical role of vascular disease in scleroderma.

    Conclusions:

    • Dr. LeRoy's vascular hypothesis has been pivotal in scleroderma research.
    • Continued investigation into vascular disease is essential for scleroderma treatment.
    • The review synthesizes key learnings about vascular pathology in scleroderma.